Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Incyte 1.674, Baxter International 2.96.
Incyte vs Baxter International: Revenue Comparison
Incyte (INCY) and Baxter International (BAX) are peers in Healthcare. Incyte reported revenue of $1.7B as of Q2 2026, compared with $3.0B for Baxter International. Baxter International leads on revenue.
Incyte's gross margin is 93.7% versus 34.9% for Baxter International. Incyte's net margin is 35.0% versus 4.3% for Baxter International.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Incyte, Baxter International.| Metric | Incyte | Baxter International |
|---|---|---|
| Market Cap | - | - |
| Revenue | $1.67B | $2.96B |
| Cost of Revenue | $105.00M | $1.93B |
| Gross Profit | $1.57B | $1.03B |
| Operating Income | $698.00M | $217.00M |
| Net Income | $586.00M | $126.00M |
| R&D Expense | $517.00M | $129.00M |
| Earnings Per Share | $2.81 | $0.24 |
| Gross Margin | 93.7% | 34.9% |
| Operating Margin | 41.7% | 7.3% |
| Net Profit Margin | 35.0% | 4.3% |
| Free Cash Flow | $495.00M | $32.00M |
| Cumulative Free Cash Flow | $3.86B | $35.82B |
| Operating Cash Flow | $508.00M | $285.00M |
| Cash & Equivalents | $3.98B | $2.15B |